Table 1.

Epidemiological traits of HPV and cancers other than cervical.

Site and histological type	Incidence (per 100.000)	HPV DNA prevalence range (%)	HPV-16 among HPV+ (%)
VULVA	0.0 – 3.5
VIN3		72 – 100	65 – 93
Vulva warty-basaloid		75 – 100	NA
Vulva squamous		2 – 23	71
VAGINA	0.0 – 1.5
VAIN		82–100	67 – 75
Vagina squamous		64 – 91	70 – 88
PENIS	0.0 – 3.7
PIN		90	41
Penis warty-basaloid		46– 100	60 – 88
Penis squamous verrucous		31 – 35	60 – 75
ANUS	0.1 – 2.8 males / 0.0 – 2.2 females
AIN		NA	NA
Anus squamous		>80	76
OROPHARYNX & TONSILS	0.3–21.5 males/0.0–2.8 females	33 – 72	72 – 87

HPV+: subjects positive to HPV DNA.

Oropharynx incidence includes codes: C09 - Tonsil, C10 - other oropharynx, C12 and C13 – hypopharynx.

AIN: Anal intraepithelial neoplasia; PIN: Penile intraepithelial neoplasia; VAIN: Vaginal intraepithelial neoplasia; VIN: Vulvar intraepithelial neoplasia.

Sources of data: [Table 5: a1–a5].